| Date Filed | Type | Description |
| 06/12/2023 |
4
| CHEN JIN-LONG (Director) has filed a Form 4 on Tenaya Therapeutics, Inc.|
Txns:
| Granted 29,532 options to buy
@ $7.12, valued at
$210.3k
|
|
| 03/06/2023 |
4
| CHEN JIN-LONG (Chief Scientific Officer) has filed a Form 4 on NGM BIOPHARMACEUTICALS INC|
Txns:
| Granted 64,000 shares
@ $0
Granted 192,000 options to buy
@ $4.36, valued at
$837.1k
Granted 175,000 options to buy
@ $4.36, valued at
$763k
|
|
| 01/18/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/13/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/04/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/07/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/16/2021 |
4
| CHEN JIN-LONG (Chief Scientific Officer) has filed a Form 4 on NGM BIOPHARMACEUTICALS INC|
Txns:
| Sold 15,000 shares
@ $19.89, valued at
$298.4k
Sold 15,000 shares
@ $19.56, valued at
$293.4k
|
|
| 10/13/2021 |
4
| CHEN JIN-LONG (Chief Scientific Officer) has filed a Form 4 on NGM BIOPHARMACEUTICALS INC|
Txns:
| Sold 15,000 shares
@ $20.41, valued at
$306.2k
Sold 15,000 shares
@ $20.14, valued at
$302.1k
|
|
| 09/14/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/11/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/29/2021 |
3
| CHEN JIN-LONG (Director) has filed a Form 3 on Tenaya Therapeutics, Inc. |
| 06/07/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/04/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/13/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/18/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/17/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/06/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/16/2020 |
4
| CHEN JIN-LONG (Chief Scientific Officer) has filed a Form 4 on NGM BIOPHARMACEUTICALS INC|
Txns:
| Sold 11,126 shares
@ $27.59, valued at
$307k
Sold 10,729 shares
@ $28.19, valued at
$302.5k
Sold 3,145 shares
@ $28.89, valued at
$90.9k
|
|
| 11/04/2020 |
4
| CHEN JIN-LONG (Chief Scientific Officer) has filed a Form 4 on NGM BIOPHARMACEUTICALS INC|
Txns:
| Sold 25,000 shares
@ $17.7, valued at
$442.5k
|
|
| 10/13/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/03/2020 |
4
| CHEN JIN-LONG (Chief Scientific Officer) has filed a Form 4 on NGM BIOPHARMACEUTICALS INC|
Txns:
| Sold 17,387 shares
@ $17.62, valued at
$306.4k
Sold 7,613 shares
@ $18.32, valued at
$139.5k
|
|
| 08/11/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/02/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/17/2020 |
4
| CHEN JIN-LONG (Chief Scientific Officer) has filed a Form 4 on NGM BIOPHARMACEUTICALS INC|
Txns:
| Sold 5,600 shares
@ $21.15, valued at
$118.4k
Sold 19,400 shares
@ $21.79, valued at
$422.7k
|
|
| 02/06/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/09/2020 |
4
| CHEN JIN-LONG (Chief Scientific Officer) has filed a Form 4 on NGM BIOPHARMACEUTICALS INC|
Txns:
| Sold 16,090 shares
@ $18.2024, valued at
$292.9k
Sold 14,201 shares
@ $17.9798, valued at
$255.3k
Sold 1,833 shares
@ $17.9798, valued at
$33k
Sold 18,641 shares
@ $17.9501, valued at
$334.6k
Exercised 16,090 options to buy
@ $1.44, valued at
$23.2k
Exercised 14,201 options to buy
@ $1.44, valued at
$20.4k
Exercised 1,833 options to buy
@ $1.44, valued at
$2.6k
Exercised 71,750 options to buy
@ $0.52, valued at
$37.3k
Exercised 18,641 options to buy
@ $1.44, valued at
$26.8k
|
|
| 11/04/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/03/2019 |
3
| CHEN JIN-LONG (Chief Scientific Officer) has filed a Form 3 on NGM BIOPHARMACEUTICALS INC |